- £3.99bn
- £4.78bn
- $2.88bn
- 74
- 48
- 69
- 72
REG - Hikma Pharmaceutical - Hikma Share Buyback Programme
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Share Buyback Programme
AnnouncementREG - Hikma Pharmaceutical - Directorate Change
AnnouncementREG - Hikma Pharmaceutical - Final Results
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Notice of Results
AnnouncementREG - Hikma Pharmaceutical - Hikma completes acquisition of Teligent
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Acquisition
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Hikma Launches 503B Sterile Compounding Business
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementRCS - Hikma Pharmaceutical - Richter and Hikma sign agreement for denosumab
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
Announcement